Expanding the Indication for Novel Theranostic 177Lu-Dotatate Peptide Receptor Radionuclide Therapy: Proof-of-Concept of PRRT in Merkel Cell Cancer

The field of theranostics is a new nuclear medicine tool being utilized in the treatment of different types of cancers. It couples receptor-specific based imaging predicting and guiding response to receptor-specific based radionuclide therapies. For example, somatostatin-receptor based imaging (Gall...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasi, Pashtoon M., Sharma, Akash, Jain, Manoj K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477495/
https://www.ncbi.nlm.nih.gov/pubmed/31043945
http://dx.doi.org/10.1159/000496335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477495/
https://www.ncbi.nlm.nih.gov/pubmed/31043945
http://dx.doi.org/10.1159/000496335

Ejemplares similares